Premium
Ocular myasthenic syndrome, adverse reaction to omalizumab? A case report
Author(s) -
Kalteren Willemien S.,
Schreurs Marco W. J.,
JorritsmaSmit Annelies,
Touw Daan J.,
Jong Jan Willem,
Zweers Petra G. M. A.,
Reesink Fransje E.
Publication year - 2017
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.13338
Subject(s) - omalizumab , medicine , myasthenia gravis , immunoglobulin e , adverse effect , immunology , gastroenterology , antibody
University of Groningen, University Medical Center Groningen, The Netherlands, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, The Netherlands, Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, The Netherlands, Department of Lung Diseases, Ommelander Hospital Groningen, The Netherlands, Netherlands Pharmacovigilance Centre Lareb, The Netherlands, and Department of Neurology, Ommelander Hospital Groningen, The Netherlands